Your Search for absolute cd4 cell count matched 90 Documents (Page 1 of 3).
Results Indexed by relevance.

1. Measurement of CD4: Percentage (100%)
Abstract: AEGIS, AIDS Daily Summary, HIV, AIDS, HIV infection, opportunistic infections. var gaJsHost = (https: = document.location.protocol) ? "https:ssl. : "http:www. document.write(unescape(3Cscript src= + gaJsHost + "google-analytics.com/ga.js' type=text/javascript'3E%3C/script%3E"ion" CONTENT=Dr. Paul A. ...
http://www.aegis.org/news/ads/1994/ad941559.html
File Name: ad941559.html, Size: 10KB, Last Modified: Sunday, January 04, 2009 at 6:48:33 PM

2. AEGiS-08CROI: Cervicovaginal human papillomavirus (HPV) infection in a prospective cohort of HIV-seropositive women: comprehensive molecular profiles and predictors of HPV persistence. (100%)
Abstract: <p><b>BACKGROUND:</b> The objective of the study was to prospectively characterize the prevalence and evolution of cervicovaginal HPV infection in HIV-seropositive women. </p> <p><b>METHODS:</b> Study participants received biannual pelvic exams including Pap smear, cervicovaginal lavage (CVL), and STD screening. HPV D ...
http://www.aegis.org/conferences/croi/2001/723.html
File Name: 723.html, Size: 6KB, Last Modified: Sunday, February 04, 2001 at 8:12:04 PM

3. Genital shedding of human immunodeficiency virus type 1 DNA during pregnancy: association with immunosuppression, abnormal cervical or vaginal discharge, and severe vitamin A deficiency. (100%)
Abstract: The presence of human immunodeficiency virus type 1 (HIV-1) in genital secretions may be a determinant of vertical HIV-1 transmission. Cervical and vaginal secretions from HIV-1-seropositive pregnant women were evaluated to determine prevalence and correlates of HIV-1-infected cells in the genital tract. HIV-1 DNA was ...
http://www.aegis.org/aidsline/1997/apr/m9741481.html
File Name: m9741481.html, Size: 9KB, Last Modified: Monday, April 28, 1997 at 8:12:04 PM

4. Influence of different flow cytometers, monoclonal antibodies, two and three color labelling on the CD-4 cell count in HIV infection. (100%)
Abstract: INTRODUCTION: Measurement of absolute CD4 cell count still is very unsatisfactory but of importance for therapy, diagnostic and staging in HIV infection. OBJECTIVE: In an ongoing study lymphocyte subsets of 200 HIV infected individuals are measured parallely with two different flow cytometers, different commercial mon ...
http://www.aegis.org/aidsline/1994/dec/m94c1902.html
File Name: m94c1902.html, Size: 10KB, Last Modified: Wednesday, December 28, 1994 at 8:12:04 PM

5. AEGiS-10IAC: Influence of different flow cytometers, monoclonal antibodies, two and three color labelling on the CD-4 cell count in HIV infection. (100%)
Abstract: <p><b>INTRODUCTION</b>: Measurement of absolute CD4 cell count still is very unsatisfactory but of importance for therapy, diagnostic and staging in HIV infection. <p><b>OBJECTIVE</b>: In an ongoing study lymphocyte subsets of 200 HIV infected individuals are measured parallely with two different flow cytometers, d ...
http://www.aegis.org/conferences/iac/1994/pb0855.html
File Name: pb0855.html, Size: 6KB, Last Modified: Thursday, August 04, 1994 at 8:12:04 PM

6. AEGiS-14IAC: Immune responses in HIV-infected persons in China. (70%)
Abstract: <p><b>BACKGROUND:</b> Although natural HIV infection is associated with ultimate destruction of the immune system in most HIV-infected persons, it is the immune system itself that is thought to control the virus and retard disease progression . Little information is available regarding immune responses to the viruses ...
http://www.aegis.org/conferences/iac/2002/c10930.html
File Name: c10930.html, Size: 7KB, Last Modified: Monday, July 08, 2002 at 6:29:23 AM

7. Double (3TC + d4T) vs triple (3TC + d4T + Saquinavir) therapy in HIV-1 experienced patients (ZDV + ddC/ddI) with a low baseline HIV-1 viral load. (median 4,089 copies/ml). (70%)
Abstract: Objective: To assess the immunological and virological efficacy of switching antiretroviral therapy (ARVT) at low levels of plasma HIV-1RNA (VL) and to find out whether double therapy 3TC + ...
http://www.aegis.org/aidsline/1998/jun/m9860570.html
File Name: m9860570.html, Size: 10KB, Last Modified: Monday, June 29, 1998 at 6:29:23 AM

8. AEGiS-05CROI: Double (3TC + d4T) vs triple (3TC + d4T + Saquinavir) therapy in HIV-1 experienced patients (ZDV + ddC/ddI) with a low baseline HIV-1 viral load. (median 4,089 copies/ml). (70%)
Abstract: <p><b>OBJECTIVE:</b> To assess the immunological and virological efficacy of switching antiretroviral therapy (ARVT) at low levels of plasma HIV-1RNA (VL) and to find out whether double therapy ( 3TC + d4T ) has similar efficacy as triple therapy (3TC+d4T+ ...
http://www.aegis.org/conferences/croi/1998/367.html
File Name: 367.html, Size: 6KB, Last Modified: Sunday, February 01, 1998 at 8:12:04 PM

9. Chlamydia pneumoniae seroprevalence among HIV-1 infected and uninfected subjects. (70%)
Abstract: Objective: To evaluate the prevalence of Chlamydia pneumoniae Cpn) antibodies in an Italian population of HIV-infected and uninfected individuals with known HIV risk factor. Methods: A perspective evaluation of Cpn microimmunofluorescence immunoglobulin (Ig)G and IgM titer, related to gender, age, absolute CD4+ cell c ...
http://www.aegis.org/aidsline/1997/jan/m9714960.html
File Name: m9714960.html, Size: 9KB, Last Modified: Tuesday, January 28, 1997 at 8:12:04 PM

10. AEGiS-11IAC: Chlamydia pneumoniae seroprevalence among HIV-1 infected and uninfected subjects. (70%)
Abstract: To evaluate the prevalence of Chlamydia pneumoniae (Cpn) antibodies in an Italian population of HIV-infected and uninfected individuals with known HIV risk factor. <p><b>METHODS</b>: A perspective evaluation of Cpn microimmunofluorescence immunoglobulin (Ig)G and IgM titer, related to gender, age, absolute CD4+ cell ...
http://www.aegis.org/conferences/iac/1996/tub2215.html
File Name: tub2215.html, Size: 6KB, Last Modified: Sunday, July 07, 1996 at 8:12:04 PM

11. A T cell functional assay combined with measurement of CD4+/CD29bright cells is predictive of death in HIV infection. (70%)
Abstract: A cross-sectional group of 335 HIV infected patients had a T cell functional assay performed which measured in vitro IL-2 production in response to recall antigens, alloantigens, and PHA. Patients also underwent T cell subset phenotyping and clinical staging using the ...
http://www.aegis.org/aidsline/1993/nov/m93b3914.html
File Name: m93b3914.html, Size: 10KB, Last Modified: Sunday, November 28, 1993 at 8:12:04 PM

12. Acquired immunodeficiency syndrome associated T-cell lymphoma. (70%)
Abstract: The development of cutaneous T-cell lymphome (CTCL) is unusual in individuals with human immunodeficiency virus type 1 (HIV1) with only six published cases. We present a another case. REPORT OF CASE: A 39 years old white man was found to be HIV+ en 1991. Analysis of T cell markers an peripheral blood lymphocytes showe ...
http://www.aegis.org/aidsline/1993/nov/m93b4153.html
File Name: m93b4153.html, Size: 9KB, Last Modified: Sunday, November 28, 1993 at 8:12:04 PM

13. AEGiS-09IAC: A T cell functional assay combined with measurement of CD4+/CD29bright cells is predictive of death in HIV infection. (70%)
Abstract: A cross-sectional group of 335 HIV infected patients had a T cell functional assay performed which measured in vitro IL-2 production in response to recall antigens, alloantigens, and PHA. Patients also underwent T cell subset phenotyping and clinical staging using the Walter Reed criteria. During the mean 3.0 year foll ...
http://www.aegis.org/conferences/iac/1993/wsb026.html
File Name: wsb026.html, Size: 6KB, Last Modified: Sunday, June 06, 1993 at 8:12:04 PM

14. AEGiS-09IAC: Acquired immunodeficiency syndrome associated T-cell lymphoma. (70%)
Abstract: The development of cutaneous T-cell lymphome (CTCL) is unusual in individuals with human immunodeficiency virus type 1 (HIV1) with only six published cases. We present a another case. REPORT OF CASE: A 39 years old white man was found to be HIV+ en 1991. Analysis of T cell markers an peripheral blood lymphocytes showed ...
http://www.aegis.org/conferences/iac/1993/pob131625.html
File Name: pob131625.html, Size: 5KB, Last Modified: Sunday, June 06, 1993 at 8:12:04 PM

15. AEGiS-06IAC: Phase I study of 2'3' - didehydro - 2',3'- dideoxythymidine (d4T) in patients (Pts.) with AIDS or ARC (70%)
Abstract: <p><b>OBJECTIVE</b>: To evaluate the safety and efficacy of the pyrimidine analogue d4T in pts. with AIDS or ARC. <p><b>METHODOLOGY</b>: Four daily dose levels were tested: I-2mg/kg/day; II-4mg/kg/day; III-8mg/kg/day; IV-12mg/kg/day, given in 3 divided doses.</p> <p><b>RESULTS</b>: 6 AIDS and 14 ARC pts. (19 males ...
http://www.aegis.org/conferences/iac/1990/sb456.html
File Name: sb456.html, Size: 6KB, Last Modified: Wednesday, June 20, 1990 at 8:12:04 PM

16. Disappearance of CD4-lymphocyte circadian cycles in HIV-infected patients: early event during asymptomatic infection. (35%)
Abstract: Circadian variations have been observed in peripheral blood lymphocyte counts in normal subjects; they usually reflect variations in absolute CD4-cell count. For this population, nadir occurs around 0800 h (basal value) and the peak value occurs at midnight (1.6 times the 0800-h value). This cycle is thought to be of ...
http://www.aegis.org/aidsline/1988/oct/m88a0080.html
File Name: m88a0080.html, Size: 8KB, Last Modified: Wednesday, January 07, 2009 at 5:19:14 AM

17. [MoPE0058] DECLINING CD4+ CELL COUNTS DURING SUPPRESSED OR LOW LEVEL VIREMIA (35%)
Abstract: Declining CD4+ cell count in the setting of low plasma HIV RNA levels is relatively rare in our population. The vast majority of cases had plasma HIV RNA levels consistently <500 copies/ml and none were taking the didanosine/tenofovir combination, suggesting the involvement of other factors. We examined several indepen ...
http://www.aegis.org/conferences/iac/2006/mope0058.html
File Name: mope0058.html, Size: 9KB, Last Modified: Wednesday, April 23, 2008 at 8:00:00 AM

18. [P130] Characteristics of HIV-1-infected patients with immunovirological discordance in the UK (35%)
Abstract: Seventeen patients fulfilled the criteria defining immunovirological discordance, more than half of them (9/17) with a low CD4 percentage (<21%). Identification of new cases is ongoing. Significant discrepancies between viral load assays were not found, suggesting repeat testing using alternative assays is of limited b ...
http://www.aegis.org/conferences/bhiva/2007/p130.html
File Name: p130.html, Size: 7KB, Last Modified: Thursday, March 29, 2007 at 8:12:04 PM

19. AEGiS-15IAC: Prevalence and predictive factors for CCR5 and CXCR4 co-receptor usage in a large cohort of HIV-1 positive individuals. (35%)
Abstract: BACKGROUND: Viral co-receptor usage is associated with the rate of disease progression. CCR5 antagonists may not be active in the presence of dual tropic or CXCR4 tropic viruses. Factors which predict co-receptor usage may be useful to avoid the need for screening. METHODS: Samples from treatment naïve and experienced ...
http://www.aegis.org/conferences/iac/2004/wepeb5725.html
File Name: wepeb5725.html, Size: 7KB, Last Modified: Monday, July 12, 2004 at 6:29:23 AM

20. AEGiS-15IAC: Rapid and economical single-platform count of peripheral blood CD4 T cell by flow cytometry: positive comparison with conventional dual platform method. (35%)
Abstract: BACKGROUND: Peripheral blood CD4 T cell count is crucial for monitoring antiviral therapy in HIV+ patients. In several countries this analysis is too expensive, mainly for the cost of the required instruments. The determination of the percentage of these cells by flow cytometry has to be accompanied by lymphocyte count ...
http://www.aegis.org/conferences/iac/2004/mopeb3104.html
File Name: mopeb3104.html, Size: 7KB, Last Modified: Monday, July 12, 2004 at 6:29:23 AM

21. AEGiS-11CROI: A Novel and Simplified Non-FACS-based CD4+ Cell Count Method in HIV-1 Infection: CD4+ Magnetic Bead Depletion with Automated Cell Counting. (35%)
Abstract: BACKGROUND: Flow cytometry is the standard method for measuring CD4+ T-cell count. Nevertheless, the cost of the equipment and reagents are unaffordable in most developing countries. Dynabead technology has been proposed as a low-cost alternative technology for CD4 count. However, previously reported Dynabeads method, ...
http://www.aegis.org/conferences/croi/2004/963.html
File Name: 963.html, Size: 7KB, Last Modified: Sunday, February 08, 2004 at 8:12:04 PM

22. AEGiS-10CROI: No Gender Differences in Progression of HIV-related Neurological Disease. (35%)
Abstract: <p><b>BACKGROUND:</b> Plasma HIV RNA copy number is a strong prognostic marker of progression to AIDS, but a recent meta analytic study by Napravnik, Eron et al., 2002, found that women at a comparable disease stage have lower HIV RNA than men. This suggests that a comparable viral burden may be more detrimental to hea ...
http://www.aegis.org/conferences/croi/2003/703.html
File Name: 703.html, Size: 7KB, Last Modified: Monday, February 10, 2003 at 8:12:04 PM

23. AEGiS-14IAC: Effect of baseline CD4 cell count on immunological response to antiretroviral therapy in therapy-naïve HIV-1-infected individuals: analysis of the St Mary's HIV clinical database. (35%)
Abstract: <p><b>BACKGROUND:</b> To investigate the relation between CD4 cell increase and baseline values after start of HAART, adjusting for the effect of regression to the mean. </p> <p><b>METHODS:</b> We studied 480 therapy-naïve patients (390 men, 90 women) from the St Mary s Hospital HIV-1 clinical database with prethera ...
http://www.aegis.org/conferences/iac/2002/tupeb4662.html
File Name: tupeb4662.html, Size: 8KB, Last Modified: Monday, July 08, 2002 at 6:29:23 AM

24. AEGiS-14IAC: Simplified maintenance therapy with nevirapine: efficacy in actual life. (35%)
Abstract: <p><b>BACKGROUND:</b> A simplification strategy switching from protease inhibitors (PI) to nevirapine (NEV) has been successfully attempted in clinical studies, principally in patients with metabolic disorders o hard antiretroviral regimens. Our goals are analyze the efficacy and safety of a PI spa ...
http://www.aegis.org/conferences/iac/2002/mopea3009.html
File Name: mopea3009.html, Size: 8KB, Last Modified: Monday, July 08, 2002 at 6:29:23 AM

25. AEGiS-14IAC: The effect of race/ethnicity on the outcome of highly active antiretroviral therapy in HIV-1 infected patients. (35%)
Abstract: <p><b>BACKGROUND:</b> Study objectives were to assess the impact of non-Caucasian origin on the outcome of highly active antiretroviral therapy (HAART) in a system with free access to health care. </p> <p><b>METHODS:</b> The study was conducted as a multicenter, population-based cohort study in western ...
http://www.aegis.org/conferences/iac/2002/mopec3534.html
File Name: mopec3534.html, Size: 7KB, Last Modified: Monday, July 08, 2002 at 6:29:23 AM

26. [O1] CURRENT STATUS OF PATIENTS WHO STARTED HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART) DURING 1996: A DESCRIPTIVE ANALYSIS OF EUROSIDA PARTICIPANTS (35%)
Abstract: EuroSIDA patients who started HAART in 1996 seem to be doing well more than 4 years later, despite most being nucleoside reverse transcriptase inhibitor-experienced at the start of HAART. ...
http://www.aegis.org/conferences/bhiva/2002/o1.html
File Name: o1.html, Size: 5KB, Last Modified: Friday, April 19, 2002 at 8:12:04 PM

27. AEGiS-07CROI: Gender and neurological functioning in HIV infection. (35%)
Abstract: <p><b>Objective:</b> Despite increases in the number of HIV infected females over the last several years, little is known about HIV neurological disease in women. We are conducting a longitudinal study of gender differences in HIV related central and peripheral nervous system disease. </p> <p><b>METHODS:</b> At baseli ...
http://www.aegis.org/conferences/croi/2000/297.html
File Name: 297.html, Size: 6KB, Last Modified: Sunday, January 30, 2000 at 8:12:04 PM

28. Eradication of AIDS-related disseminated mycobacterium avium complex infection after 12 months of antimycobacterial therapy combined with highly active antiretroviral therapy. (35%)
Abstract: To determine if microbiologic cure of AIDS-related disseminated Mycobacterium avium complex (MAC) is possible in patients receiving highly active antiretroviral therapy (HAART), 4 patients with a history of disseminated MAC received >/=12 months of macrolide-based antimycobacterial therapy. All were asymptomatic and h ...
http://www.aegis.org/aidsline/1999/feb/a9920433.html
File Name: a9920433.html, Size: 10KB, Last Modified: Sunday, February 28, 1999 at 8:12:04 PM

29. Partial restoration of HIV specific neutralizing activity (NA) of HIV infected patients receiving antiretrovial therapy: DDI/delaviridine (DLV), AZT/DLV, DDI/AZT or DDI/AZT/DLV. (35%)
Abstract: BACKGROUND: HIV-infected patients progressively lose the ability to neutralize autologous and laboratory HIV viral isolates. In this report the effect of antiretroviral therapy on the resistance of the NA of patients with HIV-infection and its relationship to viral load and absolute CD4+ cell count were examined. METH ...
http://www.aegis.org/aidsline/1998/dec/m98c3908.html
File Name: m98c3908.html, Size: 11KB, Last Modified: Tuesday, December 29, 1998 at 6:29:23 AM

30. Relationship between didanosine exposure and surrogate marker response in human immunodeficiency virus-infected outpatients. (35%)
Abstract: We used information available from routine clinic visits to characterize the pharmacokinetics of didanosine in 82 human immunodeficiency virus-infected patients. A total of 271 blood samples were collected for the measurement of didanosine concentrations in plasma (mean +/- standard deviation [SD], 3.30 2.21 samples/p ...
http://www.aegis.org/aidsline/1998/aug/m9880218.html
File Name: m9880218.html, Size: 9KB, Last Modified: Saturday, August 29, 1998 at 6:29:23 AM

 
1 2 3 Next
 
AEGiS Search Engine. Status: The Index is up to date.